Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
US7875733B2 · kind B2 · utility
101Cited by
198References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2004 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Mar 13, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides modified oligomeric compounds and compositions of oligomeric compounds for use in the RNA interference pathway of gene modulation. The modified oligomeric compounds include siRNA and asRNA having at least one affinity modification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.